Toronto Raptors guard Fred VanVleet, along with a few of his teammates, are still struggling to get their conditioning back after long layoffs.
Toronto Raptors guard Fred VanVleet, along with a few of his teammates, are still struggling to get their conditioning back after long layoffs.
MaXpeedingRods, the leading manufacturer and supplier for high-performance automotive parts, recently announced that they will be entering racing event fields as the primary sponsor of top-drivers worldwide.
The statement came amid reports of shortages of oxygen in parts of the country that have been hit hard by the second wave of coronavirus
The world's first major travel bubble set up in the Covid pandemic allows quarantine-free visits.
Renesas Electronics Corp, a major supplier of automotive semiconductors, said on Monday it plans to restore output lost to a fire by end-May after restarting production, relying on other plants to make up for any shortfall. Renesas restarted production on the 300mm chip line at its Naka plant northeast of Tokyo on Saturday, four weeks after a fire caused by an electricity overload burned an area of 600 square meters (6,458 square feet), destroyed 23 machines and filled the sensitive clean room with smoke and soot. A return to full output at the plant will still take around 70 more days, Renesas Chief Executive Officer Hidetoshi Shibata said during an online press conference.
Today, there are 38 World Heritage Sites located in India - the 6th largest number of sites in the world. Sadly, heritage sites need institutional support to protect the tales from the past.
RCB will take great pride in the fact that Virat Kohli or Devdutt Paddikal are yet to post big scores at the top and yet the team finds itself undefeated after three matches. In the past couple of years, De Villiers has lacked that partner in the middle order. With Maxwell arriving and in form, it gives RCB more stability in the middle order.
Peter Dutton overrules decision to strip medals from SAS soldiers who served in Afghanistan. Move by new defence minister ensures 3,000 soldiers will retain meritorious unit citation unless they are convicted of war crimes
First-time buyers will get cheaper deals if they can stretch to a bigger deposit, analysts say.
Europe's biggest teams have suffered during the Covid pandemic and say they want financial stability.
Three Italian teams Juventus, Inter Milan and AC Milan released statements confirming they are among the founding teams.
When Samuel Little confessed to murdering 93 women, he inadvertently exposed a system that routinely fails society’s most vulnerable. Clémence Michallon speaks to director Joe Berlinger and executive producer Po Kutchins about a new series, ‘Confronting a Serial Killer’, that explores Little’s horrifying legacy
My alternative summer: travel writers’ plans for an epic UK adventure . With journeys to distant corners of the globe still on hold, our writers are gearing up to hike, climb, camp, and swim on home turf
Monday briefing: Fury at plot to split football Six English clubs join breakaway European Super League … UK house prices jump to record high … and toilet roll as art Liverpool and Manchester City would be two of the teams in the European Super League. Photograph: Matt McNulty - Manchester City/Manchester City FC/Getty Images
EXCLUSIVE: Vidyut Jammwal’s rise to fame has been a remarkably rapid one. He only made his screen debut in 2011, taking largely glorified extra or stuntman roles in films as he sought his break. “I wasn’t the bad guy, I was the guy next to the bad guy,” as he puts it. Flash forward ten […]
Geoffrey Macnab looks at how the streaming giant went from hated pariah of the movie industry to risk-taking home of the edgy and offbeat
Re-start of Dussafu license drilling campaign offshore Gabon BW Energy Limited is pleased to announce the re-start of a three-well drilling campaign on the Dussafu license offshore Gabon consisting of two exploration wells in the Hibiscus area and one production well on the Tortue field. The Borr Norve jack-up rig has been contracted for the campaign. The current campaign will start with the Hibiscus Extension appraisal well (DHIBM-2) which is located about 56 km from the coast in 119 m water depth. The well is planned as a vertical well to test the northern extension of the Gamba reservoir of the already discovered Hibiscus field. If the well is found to be hydrocarbon-bearing, one or two appraisal side-tracks may be drilled to further delineate the field. The appraisal well will provide new input to the ongoing Hibiscus/Ruche development project, which is currently based on the already discovered 46.1 million barrels gross 2P reserve at Hibiscus and the 24.1 million barrels discovered at Ruche and Ruche North East. The development project is planned to consist of a converted jack-up rig tied back to the FPSO with 12 development wells drilled in two phases, with first oil expected in Q1 2023. The additional reserves at Hibiscus, if proven by DHIBM-2, may lead to relocation of the first converted jack-up and the potential deployment of a second converted jack-up to fully exploit the resources in this prolific area of Dussafu. The timing of the first oil from the area would not be affected. “We are excited to begin the next phase of exploration drilling on the Hibiscus field. The Hibiscus Extension is our largest current prospect and has already been de-risked by the nearby discovery from 2019 and subsequent 3D seismic work. Working closely with the Government of Gabon and our license partners, we are looking forward to unlocking the full potential from Hibiscus and continue our development of the successful Tortue field through this drilling programme. The company expects to generate material cash flow over the next decade from the continued development of Dussafu and to deliver significant value to Gabon and the license partnership" says Carl K. Arnet, the CEO of BW Energy. Following the DHIBM-2 well, the rig will move to drill the horizontal production well, DTM-7H, at the Tortue field. Once DTM-7H is completed and hooked up along with the previously drilled DTM-6H well, this will complete the phase 2 development of Tortue and will bring the total number of producing wells at Tortue to six wells. The rig will subsequently move to drill the Hibiscus North prospect, located approximately 6 km north-northeast of the DHIBM-1 well. Hibiscus North is a separate prospect with estimated potential reserves of 10 to 40 million barrels of oil which could further enhance the resource base of the Hibiscus/Ruche area. For further information, please contact:Knut R. Sæthre, CFO BW Energy, +47 91 11 78 email@example.com About BW Energy:BW Energy is a growth E&P company with a differentiated strategy targeting proven offshore oil and gas reservoirs through low risk phased developments. The Company has access to existing FPSOs to reduce time to first oil and cashflow with lower investments than traditional offshore developments. The main assets are 73.5% of the producing Dussafu Marine Permit offshore Gabon and a 95% interest in the Maromba field in Brazil, both operated by the Company. Total net 2P+2C reserves were 242 million barrels at the start of 2021. This information is subject to the disclosure requirements pursuant to Section 5-12 the Norwegian Securities Trading Act. This stock exchange announcement was published by Una Holmen, Manager IR, BW Offshore on 19 April at 07.30 CET.
Company announcement no 4 2021 Danske Bank A/SHolmens Kanal 2 – 12DK-1092 København KTel. +45 45 14 14 0019 April 2021 Carsten Egeriis replaces Chris Vogelzang as CEO of Danske Bank A/S.Gerrit Zalm resigns from the Board of Directors The Board of Directors of Danske Bank A/S has effective today appointed Carsten Egeriis as Chief Executive Officer. He replaces Chris Vogelzang, who has informed the Board that he wishes to resign from his position. This follows a decision by the Dutch authorities to name him a suspect in connection with their investigations of potential violations of Dutch legislation relating to the prevention of money laundering at ABN AMRO. “I am very surprised by the decision by the Dutch authorities. I left ABN AMRO more than four years ago and am comfortable with the fact that I managed my management responsibilities with integrity and dedication. My status as a suspect does not imply that I will be charged. However, given the special situation Danske Bank is in and the intense scrutiny the bank is under, particularly in relation to anti-money laundering as a consequence of the still unresolved Estonia matter, I do not want speculations about my person to get in the way of the continued development of Danske Bank. Therefore, I feel that the only right thing is for me to leave. I am very sad to leave Danske Bank, which is a great company with extremely competent people, and it has been a great honor for me to lead it,” says Chris Vogelzang. “We are very sorry to see Chris Vogelzang leave Danske Bank. He has been instrumental in the initiation of the ongoing transformation of Danske Bank and the progress and results it has already created. We fully understand and respect his decision and thank him for his huge efforts. I am pleased that we have a strong and competent successor in Carsten Egeriis, who has been part of the Executive Leadership Team as Chief Risk Officer for almost four years. He has had a pivotal role in our remediation efforts and in the strengthening of the risk area over the last years and not least in the bank’s handling of the corona crisis. He has more than 20 years’ experience from the financial sector, and the Board is confident that he is the right person to lead the transformation that is already progressing well,” says Karsten Dybvad, Chairman of the Board of Directors. “We owe Chris a huge thank you for the tremendous effort he has made for Danske Bank. He has set a new direction for Danske Bank and done so in a way, which I personally have appreciated, because it really has been a team effort in the leadership team. Now, it will be my job, together with the rest of the leadership team and all our skilled colleagues, to continue this work, which I am looking forward to. With more than 3.5 million customers we have an amazing opportunity to make a difference every day and help people and businesses realise their ambitions and at the same time contribute to the societies we are part of. The better a bank we become, the better we can solve these tasks,” says Carsten Egeriis. In this context, member of the Board of Directors Gerrit Zalm has also decided to resign from the board effective today. The Board of Directors thanks him for his efforts over the past two years. Danske Bank’s Executive Leadership TeamEffective today, Danske Bank’s Executive Leadership Team consists of the following members: Carsten Rasch Egeriis, CEO Berit Behring, Head of Large Corporates & InstitutionsFrans Woelders, Chief Operating OfficerGlenn Söderholm, Head of Personal & Business customersKarsten Breum, Chief People OfficerPhilippe Vollot, Chief Compliance OfficerStephan Engels, Chief Financial Officer Danske Bank Board of Directors Contact: Stefan Singh Kailay, Head of Media Relations, tel. +45 45 14 14 00 Attachments Company announcement no 4 2021 Carsten Egeriis - English CV
ABN AMRO accepted settlement offer in the anti-money laundering investigation in the Netherlands Today ABN AMRO Bank N.V. (ABN AMRO) announced that it has accepted a settlement offer from the Dutch Public Prosecution Service (DPPS) in connection with the previously announced investigation by the DPPS into ABN AMRO's compliance with its obligations under the Dutch Anti-Money Laundering and Counter Terrorism Financing Act (Wet ter voorkoming van witwassen en financiering van terrorisme, AML/CTF Act) between 2014 and 2020. As part of this settlement, ABN AMRO will pay EUR 480 million. ABN AMRO fully cooperated with the DPPS throughout the investigation. Based on the investigation, the DPPS identified serious shortcomings in ABN AMRO's processes to combat money laundering in the Netherlands, such as the client acceptance, transaction monitoring and client exit processes (the so-called 'Client Life Cycle' processes) in the period between 2014 and 2020, as a result of which, in certain instances, clients were able to abuse ABN AMRO accounts. ABN AMRO deeply regrets the situation and recognises the seriousness of the matter, and that it has fallen short in the fulfilment of its role as gatekeeper aimed at combatting money laundering. ABN AMRO will continue to make every effort to fulfil its role as gatekeeper. ABN AMRO CEO Robert Swaak: "As a bank we do not merely have a legal, but also a moral duty to do our utmost to protect the financial system against abuse by criminals. In fulfilling this duty, we aim to make a meaningful contribution to a safer society. Regretfully, I have to acknowledge that in the past we have been insufficiently successful in properly fulfilling our important role as gatekeeper. This is unacceptable and we take full responsibility for this." In recent years, ABN AMRO had itself already identified shortcomings in the way it implemented its 'Client Life Cycle' processes. To address these shortcomings, the bank has prioritised remediation and enhancement programmes in each of the business lines of the bank over the years, as well as bank-wide with respect to transaction monitoring. ABN AMRO has invested heavily in these remediation and enhancement programmes over several years, including investments in its systems and the growth of its staff . Unfortunately, ABN AMRO has to recognise that, despite all of its efforts and intentions, its improvement programmes have not always had the desired effect, and that several shortcomings, some of which serious, have been identified in its 'Client Life Cycle' processes. In response to the identified shortcomings in its 'Client Life Cycle' processes and in order to address increasingly strict regulations and continuously evolving forms of financial crime, ABN AMRO decided to centralise the execution of the 'Client Life Cycle' processes in October of 2018. To this end, ABN AMRO set up the Detecting Financial Crime (DFC) programme and made substantial additional (financial) resources available for investments in staff, systems and processes. The DFC programme is progressing according to the timetable as agreed upon with DNB, and the programme is expected to be completed by the end of 2022. By the end of 2020, the total number of full-time employees involved in ABN AMRO's 'Client Life Cycle' processes had increased to 3,800 (one in five jobs at ABN AMRO). The bank is convinced that its current approach is the right way to systematically remediate shortcomings across the bank, and to embed this remediation in its day-to-day operations. Besides this, ABN AMRO is also actively involved in various public-private partnerships aimed at of contributing to safer society. As part of the settlement announced today, ABN AMRO agrees to pay a fine of EUR 300 million and EUR 180 million as disgorgement. The amount of the fine reflects the seriousness, scope and duration of the identified shortcomings. The amount of the disgorgement reflects the amount of costs that ABN AMRO saved according to the DPPS. The total amount of EUR 480 million will impact the bank's first quarter results in 2021. Robert Swaak: "This settlement marks the end of a painful and disappointing episode for ABN AMRO. The lessons we have learned from this experience drive us in our continued effort as gatekeepers to achieve a safer society and a financial system that meets the highest standards of integrity." ABN AMRO Press Relations ABN AMRO Investor RelationsJarco de Swart Ferdinand Vaandrager Media Relations & Public Affairs Investor Relationspressrelations@nl.abnamro.com firstname.lastname@example.org+31 20 6288900 This press release was published by ABN AMRO Bank N.V. and contains inside information within the meaning of Article 7(1) to (4) of the Regulation (EU) No 596/2014 (Market Abuse Regulation) Attachments ABN AMRO accepted settlement offer in the anti-money laundering investigation in the Netherlands Settlement Agreement ABN AMRO Guardian Statement of Facts - ABN AMRO Guardian
PRESS RELEASE Strategic partnership between ELSAN and Pharmagest Group to develop relations with private practitioners through PandaLab’s instant messaging app for medical professionals ELSAN, a leading private healthcare operator in France caring for 2 million patients each year at its 120 private clinics and hospitals, and Pharmagest Group, the majority shareholder of PandaLab, finalize a strategic partnership to optimize interactions and information flows between hospital and private practice office-based healthcare professionals. PandaLab makes its instant messaging app, PandaLab Pro, available to ELSAN’s 120 private clinics and hospitals.ELSAN acquires a minority stake in PandaLab. Paris and Villers-lès-Nancy, 19 April 2021 - 07:30 a.m. (CET) - After signing a partnership agreement in January 2020 with PandaLab for its secure instant messaging app for hospital and private practice office-based healthcare professionals, ELSAN, a leading private healthcare operator in France, entered into a strategic partnership with the Health and Social Care Facilities Solutions (HSCFS) Division of Pharmagest Group (Euronext Paris™ - Compartment B - ISIN: FR 0012882389), managed by its subsidiary MALTA INFORMATIQUE, to develop relations with private practice office-based healthcare professionals through the health sector instant messaging app developed by PandaLab, a Pharmagest Group subsidiary. To solidify this partnership, ELSAN acquired a minority stake in the start-up, joining its founders and Pharmagest Group, the reference shareholder, whose majority stake remains unchanged (at 56.27% of PandaLab’s capital since April 2020). This strategic partnership will accelerate PandaLab’s deployment in France by equipping ELSAN network of private clinics and hospitals with its PandaLab Pro solution. It will also contribute the goal of the HSCFS Division, operating under the direction of MALTA INFORMATIQUE, a Pharmagest Group subsidiary, of establishing PandaLab Pro as a key tool for communications between all healthcare professionals, whether in private practice, social care establishments or hospitals in France and in Europe. PandaLab Pro, an intuitive, easy-to-use, multifunctional and secure tool for sharing health data with private practice office-based physicians, whose adoption has been accelerated by the health crisis In the context of the health crisis where healthcare professionals need to be informed and communicate quickly, the PandaLab Pro app has been deployed in half of ELSAN's clinics and hospitals with a volume of nearly 750,000 messages in less than one year. The implementation of this intuitive and easy-to-use instant messaging app from a computer or smart phone secures and facilitates internal communications not only between healthcare professionals and other staff but also with private practice physicians through a specific module developed conjointly by PandaLab and ELSAN. In this way, establishments using PandaLab Pro facilitate the work of private practice healthcare professionals by offering them a seamless and secure communications tool. Nearly 800 private practice healthcare professionals have already been invited to join the groups formed within ELSAN’s private hospitals relating to their activity. This tool makes it possible to enter directly into contact with the relevant department or medical team, obtain an opinion by the establishment’s practitioners, transfer an x-ray, rapidly obtain a response or be directed to the right correspondent. PandaLab Pro is thus for example used between the medical services of ELSAN’s private hospitals and senior homes, between hospital pharmacists and independent pharmacies or by chronic wound care units to communicate with domiciliary nurses. This tool adapts to each communications need with ambitious goals: improving the efficiency of care, improving the quality of the interaction, reducing time required to obtain information. Simon LEVY, Executive Vice President for Strategy and Development at ELSAN commented: “Our investment in PandaLab will accelerate its deployment by developing communications between hospital and private practice healthcare professionals to improve coordination in providing care to the two million patients we receive each year." Grégoire de ROTALIER, Deputy Managing Director of Pharmagest Group and Head of Pharmagest Group's Health and Social Care Facilities Solutions Division added: “PandaLab’s integration into all our software applications (pharmacies, senior homes, hospitals-at-home, in-home nursing services, hospitals, health centres and private practice physicians) combined with ELSAN’s extensive regional network of private clinics and hospitals will help establish PandaLab as a major tool for communications between hospital and private practice healthcare professionals." Christelle MASSON, Chief Executive Officer of PandaLab concluded: “We are very proud that ELSAN has decided to join our shareholder base alongside Pharmagest Group. This will allow us to accelerate the rollout of PandaLab Pro in France and continue to demonstrate the utility of this application for the coordination of the patient care pathway”. About ELSANFrance’s foremost private healthcare provider, ELSAN has a strong presence throughout the country meeting patient needs in all areas. ELSAN has 25,000 employees and 6,500 privately operating practitioners at 120 clinics and hospitals in all parts of France, providing treatment and services to more than two million patients a year. Our mission: delivering innovative, high-quality care with a human touch. www.elsan.care About PandaLab - www.pandalab.frPandaLab, the developer of e-Health software solution, PandaLab Pro, is a French start-up founded by Dr. Aurélien LAMBERT, a medical oncologist. The application for healthcare professionals and medical secretaries has more than 7,500 paying users throughout France. PandaLab is a cutting edge provider of e-Health solutions designed to coordinate and streamline the entire patient care pathway. PandaLab has been a Pharmagest Group subsidiary since 2020. About MALTA INFORMATIQUE and the Health and Social Care Facilities Solutions Division of Pharmagest Group MALTA INFORMATIQUE, a wholly-owned subsidiary of Pharmagest Group, is an independent software vendor specialised in applications for senior homes and day care facilities for the elderly, a fast-growing sector in which it has a 28 % market share. Its TITAN application is the only solution on the market with the ability to cover the entire medication pathway for senior homes. At 31 December 2020, MALTA INFORMATIQUE equipped 2,220 senior homes.MALTA INFORMATIQUE is the operating company responsible for spearheading Pharmagest Group's Health and Social Care Facilities Solutions Division (189 employees; 2019 sales: €26.19 million; installed base: more than 3,500 establishments). With its subsidiaries DICSIT INFORMATIQUE, AXIGATE, ICT, PANDALAB and MALTA BELGIUM, this Division also operates across a number of sectors including e-Health, hospitals at home, home-based nursing services, hospitals and health centres and facilities housing multiple disciplines. About Pharmagest Group: www.pharmagest.com - Follow Pharmagest on Twitter: @Pharmagest, LinkedIn and FacebookWith more than 1,100 employees acting as “Citizens in the Service of Health and Well-Being”, Pharmagest Group is the leading provider of IT solutions for the healthcare sector in Europe through innovative solutions and services for healthcare professionals guaranteeing the efficiency of the healthcare system and improving the patient care pathway.As a key contributor to the quality of healthcare and coordination between office-based private practice and hospitals, Pharmagest Group is present in France, Italy, Belgium, Luxembourg and the United Kingdom where it is developing the leading healthcare platform and a single ecosystem for France and Europe bringing the best of technology to the service of people. Listed on Euronext Paris™ - Compartment BIndices: MSCI GLOBAL SMALL CAP - GAÏA Index 2020 - CAC® SMALL and CAC® All-TradableIncluded under the European Rising Tech label Eligible for the “long-only” Deferred Settlement Service (“Service à Règlement Différé” - SRD) and equity savings accounts invested in small and mid caps (PEA-PME)ISIN: FR 0012882389 – Reuters: PHA.PA – Bloomberg: - PMGI FP CONTACTS ELSANPress Contact: Pénélope de FOUQUIERESTel.: +33 (0)6 31 34 81 24 – email@example.com MALTA INFORMATIQUEChairman and Head of Pharmagest Group's Health and Social Care Facilities Solutions Division. Grégoire de ROTALIERTel.: +33 (0)5 57 35 19 25 – firstname.lastname@example.org PANDALABChief Executive Officer: Christelle MASSONTel.: +33 (0)1 84 25 79 21 – email@example.com PHARMAGEST GROUPPress Contact: Isabelle APRILEMobile: +33 (0)6 17 38 61 78 – firstname.lastname@example.org Attachment PHARMAGEST_PRESSRELEASE_20210419_STRATEGIC PARTNERSHIP WITH ELSAN
BOUSSARD & GAVAUDAN HOLDING LIMITED Ordinary Shares The Directors of Boussard & Gavaudan Holding Limited would like to announce the following information for the Company. Close of business 16 Apr 2021. Estimated NAV Euro SharesSterling SharesEstimated NAV€ 26.8276£ 23.3825Estimated MTD return1.72%1.57%Estimated YTD return3.44%2.70%Estimated ITD return168.28%133.82% NAV and returns are calculated net of management and performance fees Market information Euro SharesAmsterdam (AEX)London (LSE)Market Close€ 21.30N/APremium/discount to estimated NAV-20.60%N/A Sterling SharesAmsterdam (AEX)London (LSE)Market CloseN/AGBX 1,800.00Premium/discount to estimated NAVN/A-23.02% Transactions in own securities purchased into treasury Ordinary Shares Euro SharesSterling SharesNumber of sharesN/AN/AAverage PriceN/AN/ARange of PriceN/AN/A Liquidity Enhancement AgreementEuro SharesSterling SharesNumber of sharesN/AN/AAverage PriceN/AN/A BGHL Capital BGHL Ordinary SharesEuro SharesSterling SharesShares Outstanding 12,945,769 294,494Held in treasuryN/AN/AShares Issued 12,945,769 294,494 Estimated BG Fund NAV Class B Euro Shares (estimated)€ 226.7813Class GBP A Shares (estimated)£ 124.4063 The Class B Euro Shares of BG Fund are not subject to investment manager fees, as the Investment Manager receives management fees and performance fees in respect of its role as Investment Manager of BGHL. For further information please contact: Boussard & Gavaudan Investment Management, LLP. Emmanuel Gavaudan +44 (0) 20 3751 5389 Email : email@example.com The Company is established as a closed-ended investment company domiciled in Guernsey. The Company has received the necessary approval of the Guernsey Financial Services Commission and the States of Guernsey Policy Council. The Company is registered with the Dutch Authority for the Financial Markets as a collective investment scheme pursuant to article 2:73 in conjunction with 2:66 of the Dutch Financial Supervision Act (Wet op het financieel toezicht). The shares of the Company (the "Shares") are listed on Euronext Amsterdam. The Shares are also listed on the Official List of the UK Listing Authority and admitted to trading on the London Stock Exchange plc's main market for listed securities. This is not an offer to sell or a solicitation of any offer to buy any securities in the United States or in any other jurisdiction. This announcement is not intended to and does not constitute, or form part of, any offer or invitation to purchase any securities or the solicitation of any vote or approval in any jurisdiction, nor shall there be any sale, issuance or transfer of the securities referred to in this announcement in any jurisdiction in contravention of applicable law. Neither the Company nor BG Fund ICAV has been, and neither will be, registered under the US Investment Company Act of 1940, as amended (the "Investment Company Act"). In addition the securities referenced in this announcement have not been and will not be registered under the US Securities Act of 1933, as amended (the "Securities Act"). Consequently any such securities may not be offered, sold or otherwise transferred within the United States or to, or for the account or benefit of, US persons except in accordance with the Securities Act or an exemption therefrom and under circumstances which will not require the issuer of such securities to register under the Investment Company Act. No public offering of any securities will be made in the United States. You should always bear in mind that: all investment is subject to risk; results in the past are no guarantee of future results; the investment performance of BGHL may go down as well as up. You may not get back all of your original investment; and if you are in any doubt about the contents of this communication or if you consider making an investment decision, you are advised to seek expert financial advice. This communication is for information purposes only and the information contained in this communication should not be relied upon as a substitute for financial or other professional advice. Attachment Daily NAV - BgHL